
Oxford Nanopore Technologies is headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices and a commercial presence in many global locations across the US, APAC and Europe. The company’s goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere.
Oxford Nanopore has developed a new generation of nanopore-based sensing technology, enabling the real-time, high-performance, accessible and scalable analysis of DNA and RNA. The technology is used in more than 100 countries to understand the biology of humans and diseases, plants, animals, bacteria, viruses, and whole environments. Oxford Nanopore’s sequencing platform is the only technology that offers real-time analysis in fully scalable formats, from pocket to population-scale, and the only one that can sequence native DNA or RNA samples, with no restriction on read length.
We are seeking a Oligonucleotide Development Scientist to join our oligonucleotide development team. This is an exciting opportunity to work within a collaborative multidisciplinary environment focused on continuous process improvement and developing high-quality sequencing products.
As part of the oligonucleotide development team, you will contribute to defining technical requirements and specifications, facilitate oligonucleotide sourcing, and resolving oligonucleotide-related product performance and manufacturing challenges
In this role, you will apply your expertise in analytical and oligonucleotide chemistry to support oligonucleotide characterisation and stability studies, process development and supplier technical evaluation. This role is ideal for someone with strong laboratory experience, excellent communication and collaborative skills, and a proactive approach to problem-solving.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.

Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.